Your browser is no longer supported. Please, upgrade your browser.
Settings
ANVS [AMEX]
Annovis Bio, Inc.
Index- P/E- EPS (ttm)-1.20 Insider Own12.90% Shs Outstand7.37M Perf Week-9.22%
Market Cap221.49M Forward P/E- EPS next Y-2.77 Insider Trans2.28% Shs Float5.64M Perf Month-23.51%
Income-8.40M PEG- EPS next Q-0.44 Inst Own19.60% Short Float8.93% Perf Quarter-38.21%
Sales- P/S- EPS this Y-498.10% Inst Trans-2.00% Short Ratio0.99 Perf Half Y19.15%
Book/sh6.60 P/B4.07 EPS next Y-60.60% ROA-46.20% Target Price70.00 Perf Year428.09%
Cash/sh5.97 P/C4.50 EPS next 5Y- ROE-48.40% 52W Range4.14 - 132.00 Perf YTD256.50%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-79.86% Beta-
Dividend %- Quick Ratio56.00 Sales past 5Y- Gross Margin- 52W Low542.27% ATR2.26
Employees2 Current Ratio56.00 Sales Q/Q- Oper. Margin- RSI (14)38.48 Volatility5.20% 8.20%
OptionableNo Debt/Eq0.00 EPS Q/Q-1.80% Profit Margin- Rel Volume0.26 Prev Close26.88
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume511.02K Price26.59
Recom2.00 SMA20-6.44% SMA50-18.12% SMA200-36.48% Volume62,634 Change-1.08%
Jul-07-21Reiterated Maxim Group Buy $45 → $150
Oct-18-21 08:10AM  
07:00AM  
Oct-15-21 09:00PM  
08:56PM  
04:21PM  
01:42PM  
08:15AM  
Oct-14-21 07:10PM  
04:20PM  
01:11PM  
08:15AM  
06:13AM  
Oct-13-21 10:00PM  
03:30PM  
12:00PM  
11:00AM  
11:00AM  
10:45AM  
10:20AM  
08:49AM  
08:30AM  
Oct-12-21 10:49PM  
09:06PM  
08:10PM  
06:40PM  
05:28PM  
04:30PM  
04:30PM  
03:37PM  
03:10PM  
03:03PM  
01:38PM  
12:45PM  
12:15PM  
09:20AM  
08:30AM  
06:28AM  
05:40AM  
Oct-11-21 11:55PM  
10:47PM  
06:17PM  
05:15PM  
04:25PM  
04:15PM  
03:25PM  
11:13AM  
11:00AM  
09:34AM  
09:15AM  
09:08AM  
08:35AM  
05:26AM  
Oct-10-21 09:00PM  
04:07PM  
10:35AM  
Oct-09-21 06:05PM  
04:28PM  
10:22AM  
10:15AM  
Oct-08-21 11:45PM  
10:50PM  
07:19PM  
05:04PM  
04:45PM  
03:00PM  
02:30PM  
01:00PM  
11:55AM  
11:00AM  
09:14AM  
07:45AM  
05:30AM  
Oct-07-21 10:50PM  
10:00PM  
07:45PM  
07:21PM  
07:00PM  
06:10PM  
12:34PM  
11:00AM  
09:00AM  
08:00AM  
05:19AM  
Oct-06-21 10:50PM  
06:03PM  
04:27PM  
04:26PM  
01:35PM  
11:30AM  
10:00AM  
09:23AM  
07:55AM  
05:36AM  
Oct-05-21 11:23PM  
06:58PM  
06:50PM  
06:50PM  
05:31PM  
02:35PM  
01:00PM  
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is ANVS401, which is in Phase 2a clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, Alzheimer's disease in Down Syndrome, and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
White Mark K.DirectorOct 12Buy27.405,000137,00056,177Oct 13 04:02 PM
Maccecchini Maria-LuisaPRESIDENT AND CEOOct 11Buy27.6118,000496,980976,775Oct 13 04:00 PM
Bruck ClaudineDirectorOct 11Buy27.661815,0066,067Oct 13 04:03 PM
McCarthy ReidDirectorAug 19Buy37.6150018,8056,829Aug 23 11:36 AM